Unichem Laboratories

638.80
-21.35
(-3.23%)
Market Cap
4,497.52 Cr
EPS
-10.01
PE Ratio
54.83
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
937.95
52 Week low
472.75
PB Ratio
1.93
Debt to Equity
0.12
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,683.45 4,03,916.05 34.10 49,887.20 12.06 9,648 13.77 52.67
5,620.45 1,49,205.29 72.77 8,184.00 0.89 1,600 64.53 45.57
1,461.90 1,18,065.10 23.53 26,520.70 14.17 4,155 47.38 52.92
3,056.05 1,03,430.62 56.27 10,785.70 11.59 1,656 13.54 47.23
1,107.95 92,448.55 17.17 28,905.40 12.36 5,578 1.69 30.37
2,201.15 90,812.16 43.84 10,615.60 19.57 1,942 -16.38 35.15
1,968.45 89,800.21 31.28 20,141.50 19.94 1,936 38.82 43.62
883.10 88,860.52 19.73 19,831.50 13.82 3,831 29.92 40.81
1,094.75 63,583.26 18.24 29,559.20 17.55 3,169 -10.04 43.94
29,597.00 62,891.56 47.49 6,097.20 10.80 1,201 16.01 49.75
Growth Rate
Revenue Growth
25.70 %
Net Income Growth
-65.13 %
Cash Flow Change
119.61 %
ROE
-64.10 %
ROCE
-74.64 %
EBITDA Margin (Avg.)
-1,588.24 %

Quarterly Financial Results

Quarterly Financials
Mar 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Revenue
216
278
260
293
331
402
300
296
300
303
334
328
342
282
314
293
326
384
318
338
319
407
432
421
545
438
450
516
547
Expenses
192
260
276
318
325
350
294
295
292
277
305
288
296
255
300
284
313
302
311
352
345
419
395
407
435
532
403
452
448
EBITDA
24
18
-16
-25
5
52
6
1
8
26
29
40
46
27
14
9
13
83
7
-14
-26
-12
37
14
110
-94
47
64
99
Operating Profit %
-3 %
-10 %
-14 %
-22 %
-7 %
7 %
-7 %
-10 %
-6 %
5 %
4 %
9 %
9 %
7 %
-1 %
2 %
-0 %
19 %
-0 %
-7 %
-14 %
-4 %
7 %
2 %
7 %
-23 %
10 %
11 %
16 %
Depreciation
11
14
14
16
18
19
18
21
20
23
21
21
21
22
22
22
23
23
25
28
31
30
29
30
32
27
28
32
31
Interest
0
3
1
1
1
4
1
2
2
2
1
1
1
2
1
2
1
2
3
5
4
6
6
7
6
5
4
5
7
Profit Before Tax
13
2
-31
-43
-14
29
-14
-22
-13
0
7
18
24
3
-9
-16
-11
58
-21
-47
-61
-47
2
-22
73
-126
15
27
62
Tax
-16
4
-10
-2
-14
-9
-8
1
1
18
5
9
-0
3
2
-3
3
-14
3
23
3
-3
3
3
0
3
6
3
4
Net Profit
29
-2
-21
-41
-0
38
-6
-22
-15
-17
2
9
24
-0
-12
-13
-14
72
-23
-71
-64
-44
-1
-25
73
-129
9
25
58
EPS in ₹
3.19
0.00
-2.91
-5.83
-0.04
4.51
-0.88
-3.15
-2.07
-2.44
0.35
1.24
3.35
-0.06
-1.63
-1.82
-2.01
10.15
-3.32
-10.04
-9.08
-6.28
-0.09
-3.48
10.39
-18.37
1.31
3.50
8.22

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Total Assets
1,169
1,284
1,527
3,194
3,150
3,145
3,126
3,319
3,193
3,169
Fixed Assets
416
403
491
578
810
870
884
990
1,257
1,196
Current Assets
564
600
749
2,337
2,038
1,687
1,377
1,648
1,589
1,694
Capital Work in Progress
123
237
250
238
92
331
568
494
148
123
Investments
35
14
14
901
926
550
392
264
2
1
Other Assets
595
630
772
1,476
1,321
1,395
1,282
1,571
1,787
1,849
Total Liabilities
1,169
1,284
1,527
3,194
3,150
3,145
3,126
3,319
3,193
3,169
Current Liabilities
212
243
393
464
503
567
506
552
640
708
Non Current Liabilities
89
86
70
50
27
47
63
148
118
99
Total Equity
868
954
1,064
2,680
2,620
2,531
2,557
2,618
2,435
2,362
Reserve & Surplus
849
936
1,045
2,666
2,606
2,517
2,543
2,604
2,421
2,348
Share Capital
18
18
18
14
14
14
14
14
14
14

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Net Cash Flow
-25
-7
-1
655
-616
-78
-154
32
75
-33
Investing Activities
-52
-85
-128
1,648
-286
-36
-66
100
241
57
Operating Activities
78
112
68
-112
-328
20
33
-260
-85
17
Financing Activities
-51
-33
59
-881
-2
-62
-121
191
-81
-106

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Promoter
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
50.93 %
70.21 %
70.22 %
70.22 %
70.22 %
70.22 %
70.22 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.83 %
0.00 %
0.90 %
0.89 %
0.94 %
1.06 %
DIIs
8.49 %
8.49 %
8.49 %
8.49 %
8.49 %
8.38 %
7.55 %
8.20 %
8.16 %
7.39 %
10.32 %
9.29 %
11.27 %
11.58 %
11.67 %
11.63 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
30.48 %
30.39 %
30.50 %
30.27 %
29.81 %
29.95 %
30.17 %
30.99 %
30.91 %
26.86 %
15.80 %
15.63 %
15.12 %
14.80 %
14.58 %
14.47 %
Others
10.09 %
10.19 %
10.08 %
10.31 %
10.77 %
10.73 %
11.34 %
9.87 %
9.99 %
14.81 %
2.84 %
4.85 %
2.49 %
2.50 %
2.60 %
2.62 %
No of Share Holders
0
33,734
34,258
33,892
35,313
33,557
32,666
29,573
29,418
26,642
21,584
20,877
21,171
20,621
20,374
21,472

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 3 5 4 4 4 4 4 0.00 0.00
Dividend Yield (%) 0.00 1.05 2.57 2.57 1.29 1.54 1.39 0.81 0.00 0.00

Corporate Action

Announcements

USFDA Approval For CompanyS Pithampur API Facility
Mar 01, 2025, 12:50
Board Meeting Outcome for Outcome Of Board Meeting
Mar 01, 2025, 12:42
Announcement under Regulation 30 (LODR)-Credit Rating
Feb 18, 2025, 18:01
Announcement under Regulation 30 (LODR)-Newspaper Publication
Feb 07, 2025, 12:01
Integrated Filing (Financial)
Feb 06, 2025, 14:53
Financial Results
Feb 06, 2025, 13:48
Included Mr. Utkarsh Patil Chief Manufacturing Officer - Formulations As A Senior Management Personnel Under SEBI LODR Regulations With Effect From 6Th February 2025
Feb 06, 2025, 13:37
Board Meeting Outcome for Unaudited Financial Results (Consolidated & Standalone) For The Quarter And Nine-Months Ended 31St December 2024
Feb 06, 2025, 13:23
Announcement Under Regulation 30(LODR) - GST (Goods &Services Tax)
Jan 27, 2025, 17:32
Disclosure Under Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015.
Jan 24, 2025, 19:14
Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2024.
Jan 14, 2025, 11:34
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
Jan 07, 2025, 17:21
Intimation By Registrar & Transfer Agent (RTA)
Jan 03, 2025, 10:44
Resignation Of Senior Managerial Personnel.
Dec 17, 2024, 15:44
Announcement under Regulation 30 (LODR)-Newspaper Publication
Nov 14, 2024, 14:48
Amendment In Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information
Nov 13, 2024, 18:00
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 13, 2024, 15:59
Board Meeting Outcome for Unaudited Financial Statements (Consolidated & Standalone) For The Second Quarter And Half Year Ended 30Th September 2024
Nov 13, 2024, 14:08
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Nov 10, 2024, 15:08
Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended September 30, 2024.
Oct 25, 2024, 16:18
Reply Letter On A Significant Increase In The Volume.
Oct 23, 2024, 10:57
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Oct 11, 2024, 10:35
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Oct 04, 2024, 17:28
Board Meeting Outcome for Outcome Of Board Meeting
Sep 30, 2024, 16:55
Closure of Trading Window
Sep 23, 2024, 09:06
Board Meeting Intimation for Integration And Consolidation Of The Generics FormulationsBusiness In The US Market.
Sep 23, 2024, 08:59
Intimation Under Regulation 30 Of SEBI LODR
Sep 10, 2024, 13:04
Announcement under Regulation 30 (LODR)-Newspaper Publication
Sep 03, 2024, 11:37
Announcement under Regulation 30 (LODR)-Change in Registered Office Address
Sep 03, 2024, 11:33
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Aug 23, 2024, 16:53
Announcement under Regulation 30 (LODR)-Newspaper Publication
Aug 09, 2024, 13:04
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Aug 08, 2024, 17:51
Shareholder Meeting / Postal Ballot-Outcome of AGM
Aug 08, 2024, 17:44
Change In Key Managerial Personnel For Determining And Disclosure Of Material Events
Aug 08, 2024, 15:36
Board Meeting Outcome for Outcome Of Board Meeting
Aug 08, 2024, 13:05
Outcome Of Board Meeting
Aug 08, 2024, 13:01
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Aug 05, 2024, 09:50
Board Meeting Intimation for Financial Results
Jul 26, 2024, 10:17
USFDA Inspection At Goa Formulation Facility
Jul 15, 2024, 17:53
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jul 12, 2024, 13:24
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Jul 11, 2024, 17:06
Notice Of The 61St Annual General Meeting
Jul 11, 2024, 10:49
Business Responsibility and Sustainability Reporting (BRSR)
Jul 11, 2024, 10:29
Reg. 34 (1) Annual Report.
Jul 11, 2024, 10:22
Announcement under Regulation 30 (LODR)-Newspaper Publication
Jul 01, 2024, 16:29
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Jul 01, 2024, 16:11
Shareholder Meeting - AGM On August 8, 2024
Jun 28, 2024, 11:32
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015
Jun 27, 2024, 17:34
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Jun 26, 2024, 10:52
Closure of Trading Window
Jun 25, 2024, 16:51

Technical Indicators

RSI(14)
Neutral
41.02
ATR(14)
Less Volatile
36.84
STOCH(9,6)
Neutral
61.14
STOCH RSI(14)
Neutral
73.28
MACD(12,26)
Bullish
1.50
ADX(14)
Weak Trend
16.26
UO(9)
Bearish
40.46
ROC(12)
Downtrend And Accelerating
-7.17
WillR(14)
Neutral
-64.33